ASX:DRUG Holdings Information

ASX:DRUG is an equity ETF with a total of 81 individual holdings. The top holdings are Eli Lilly and Company stock at 9.39%, Johnson & Johnson at 8.14%, AbbVie at 5.86%, UnitedHealth Group at 5.45%, and ROCHE HOLDING AG at 5.26%.

Total Holdings

Top 10 Percentage

53.26%

Asset Class

Equity

ETF Category

Health Care

Assets

157.95M

PE Ratio

21.39

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	9.39%	9,551
2	JNJ	Johnson & Johnson	8.14%	40,446
3	ABBV	AbbVie Inc.	5.86%	30,734
4	UNH	UnitedHealth Group Incorporated	5.45%	16,326
5	ROP.SE	ROCHE HOLDING AG	5.26%	14,374
6	LON: AZN	AstraZeneca PLC	5.17%	32,090
7	MRK	Merck & Co., Inc.	4.24%	40,575
8	NOVN.SE	NOVARTIS AG	3.90%	29,607
9	TMO	Thermo Fisher Scientific Inc.	3.05%	7,168
10	AMGN	Amgen Inc.	2.82%	9,601
11	NOVOB.DC	NOVO NORDISK A/S	2.73%	68,288
12	GILD	Gilead Sciences, Inc.	2.63%	22,111
13	ISRG	Intuitive Surgical, Inc.	2.36%	6,400
14	ABT	Abbott Laboratories	2.36%	31,318
15	PFE	Pfizer Inc.	2.34%	102,483
16	DHR	Danaher Corporation	2.01%	12,745
17	LON: GSK	GSK plc	1.92%	85,551
18	SYK	Stryker Corporation	1.87%	6,978
19	BMY	Bristol-Myers Squibb Company	1.82%	36,703
20	SAN.FP	SANOFI	1.73%	22,238
21	MDT	Medtronic plc	1.52%	23,139
22	VRTX	Vertex Pharmaceuticals Incorporated	1.43%	3,663
23	ELV	Elevance Health, Inc.	1.35%	3,931
24	EL.FP	ESSILORLUXOTTICA SA	1.19%	6,680
25	CI	The Cigna Group	1.18%	4,750

Showing 25 of 81 holdings

Subscribe to see the full list

Activate Now

As of May 28, 2026